Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oxbridge Re Holdings (OXBR) Liabilities and Shareholders Equity (2016 - 2025)

Oxbridge Re Holdings (OXBR) has disclosed Liabilities and Shareholders Equity for 12 consecutive years, with $8.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 20.91% to $8.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $35.8 million, a 16.61% increase, with the full-year FY2024 number at $7.5 million, down 9.55% from a year prior.
  • Liabilities and Shareholders Equity was $8.9 million for Q3 2025 at Oxbridge Re Holdings, down from $9.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $18.7 million in Q2 2023 to a low of $7.3 million in Q1 2024.
  • A 5-year average of $12.3 million and a median of $10.3 million in 2025 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 94.75% in 2021, then plummeted 58.18% in 2024.
  • Oxbridge Re Holdings' Liabilities and Shareholders Equity stood at $17.7 million in 2021, then fell by 6.07% to $16.6 million in 2022, then plummeted by 50.33% to $8.3 million in 2023, then dropped by 9.55% to $7.5 million in 2024, then rose by 18.61% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for OXBR's Liabilities and Shareholders Equity are $8.9 million (Q3 2025), $9.2 million (Q2 2025), and $10.3 million (Q1 2025).